Asia-Pacific Proteomics Market Size (2024 - 2029)

The Asia-Pacific proteomics market is projected to experience significant growth, driven by the expanding applications of proteomics in clinical settings and the increasing involvement of government initiatives to enhance the biotechnology sector. The market's expansion is supported by strategic developments during the COVID-19 pandemic, which highlighted the importance of proteomics in understanding and combating infectious diseases. Despite challenges such as the high cost of instruments, the market is expected to benefit from improved research activities and infrastructure investments, contributing to its overall market size growth over the forecast period.

Market Size of Asia-Pacific Proteomics Industry

Asia-Pacific Proteomics Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2021 - 2022
CAGR 7.60 %
Market Concentration Medium

Major Players

Asia-Pacific Proteomics Market Major Players

*Disclaimer: Major Players sorted in no particular order

APAC Proteomics Market Analysis

Asia-Pacific Proteomics Market is expected to register a CAGR of 7.6% over the forecast period.

During the COVID-19 pandemic, proteomics helped in various ways. Few market players undertook strategic initiatives during the pandemic, which boosted the market growth. For instance, in April 2021, Shionogi & Co., Ltd. and Sysmex Corporation reported that HISCL TARC Assay Kit, a Th2 chemokine (TARC) kit, was approved for an additional indication as an auxiliary for assessment of aggravation risk in patients testing positive for SARS-CoV-2. The development of therapeutic and preventive strategies requires an accurate understanding of proteins' role in the SARS-CoV-2 infection process and progression of COVID-19. However, due to the temporary shutdown of research institutes and less manpower, performing research activities normally during the COVID-19 pandemic was difficult. But, with time, the situation gradually improved, which is expected to support the market growth over the forecast period.

The widening applications of proteomics are contributing largely to market growth. For instance, according to the data from MDPI published in February 2021, proteomic analysis is one of the leading approaches with increasing significance in clinical applications that are associated with the development of high-performance instruments that allow for the identification of disease-specific biomarkers and rapid protein profiling of the analyzed samples. Therefore, with the implementation of proteomics for infectious disease therapeutics, the cell-free protein expression market is expected to grow during the study period.

Additionally, the involvement of the government in the betterment of the biotechnology industry is fueling the market growth. For instance, as per a May 2020 update by the India Brand Equity Foundation (IBEF), in the Union Budget 2022-23, the Department of Biotechnology was allotted Rs. 2,581 crores (USD 343.56 million) for developing basic infrastructure, genetic engineering, technologies, and bioinformatics, agriculture biotechnology, and training skilled professionals. This is anticipated to boost the number of research and development activities about protein identification and will contribute to the growth of the market studied.

However, the high cost of instruments is believed to hinder market growth over the forecast period.

APAC Proteomics Industry Segmentation

Proteomics is the study of protein structure and function. A proteome is a set of proteins produced in an organism, system, or biological context. The Asia-Pacific Proteomics Market is segmented by Type (Instrument (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Other Instrumentation Technologies), Reagents, Software and Services), Applications (Clinical Diagnostics, Drug Discovery, Other Applications), and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.

By Type
Instrument
Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Other Instrumentation Technologies
Reagents
Software and Services
By Application
Clinical Diagnostics
Drug Discovery
Other Applications
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region Or Segment?
Customize Now

Asia-Pacific Proteomics Market Size Summary

The Asia-Pacific proteomics market is poised for significant growth, driven by the expanding applications of proteomics in various fields, including drug discovery and development. The market is experiencing a surge in interest due to its critical role in identifying disease-specific biomarkers and enhancing the understanding of protein functions. This growth is further supported by strategic initiatives undertaken by key players during the COVID-19 pandemic, which highlighted the importance of proteomics in understanding viral infections and developing therapeutic strategies. Government support, particularly in countries like India, is also contributing to market expansion through increased funding for biotechnology and bioinformatics infrastructure, which is expected to boost research and development activities in protein analysis.

The market's growth trajectory is supported by technological advancements in protein assay techniques and the rising prevalence of chronic and infectious diseases, which are driving demand for novel diagnostic solutions. The proteomics market in India, in particular, is expected to benefit from increased investments in research and development by biotechnology and pharmaceutical companies, alongside government initiatives. The involvement of global and local companies, such as Bruker Corporation, Agilent Technologies, and Bio-Rad Laboratories, is further propelling market growth through partnerships and the introduction of advanced proteomics solutions. Despite challenges such as the high cost of instruments, the market is anticipated to grow steadily, fueled by the need for efficient drug discovery processes and the development of affordable healthcare solutions.

Explore More

Asia-Pacific Proteomics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Demand for Personalized Medicine

      2. 1.2.2 Increasing R&D Expenditure and Government Funding for Proteomics

      3. 1.2.3 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Instruments

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value in USD million)

    1. 2.1 By Type

      1. 2.1.1 Instrument

        1. 2.1.1.1 Spectroscopy

        2. 2.1.1.2 Chromatography

        3. 2.1.1.3 Electrophoresis

        4. 2.1.1.4 Protein Microarrays

        5. 2.1.1.5 X-Ray Crystallography

        6. 2.1.1.6 Other Instrumentation Technologies

      2. 2.1.2 Reagents

      3. 2.1.3 Software and Services

    2. 2.2 By Application

      1. 2.2.1 Clinical Diagnostics

      2. 2.2.2 Drug Discovery

      3. 2.2.3 Other Applications

    3. 2.3 Geography

      1. 2.3.1 Asia-Pacific

        1. 2.3.1.1 China

        2. 2.3.1.2 Japan

        3. 2.3.1.3 India

        4. 2.3.1.4 Australia

        5. 2.3.1.5 South Korea

        6. 2.3.1.6 Rest of Asia-Pacific

Asia-Pacific Proteomics Market Size FAQs

The Asia-Pacific Proteomics Market is projected to register a CAGR of 7.60% during the forecast period (2024-2029)

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, GE Healthcare and Thermofischer Scientific Inc. are the major companies operating in the Asia-Pacific Proteomics Market.

Asia-Pacific Proteomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)